CADRALAZINE
UNII 8T96I3U713

Substance Identification & Data

This profile provides standardized clinical and technical data for Cadralazine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8T96I3U713.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 64241-34-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8T96I3U713

CAS Registry Number

64241-34-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CADRALAZINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H21N5O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QLTVVOATEHFXLT-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C81527

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

2515

Unique identification number in the NCBI database of chemical substances.

INN ID

4670

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1nc(NNC(=O)OCC)ccc1N(CC(O)C)CC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cadralazine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.